Finance

Beta
Lists
543245:BOM
Gland Pharma Ltd
₹2,275.00
+2.44%
(+54.10) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543245...
Open
₹2,229.40
High
₹2,288.65
Low
₹2,197.00
Mkt. cap
377.26B
Avg. vol.
39.72K
Volume
30.40K
Dividend
0.88%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
36.53
52-wk high
₹2,391.25
52-wk low
₹1,575.00
EPS
₹62.28
No. of employees
4K
Open
₹2,229.40
High
₹2,288.65
Low
₹2,197.00
Mkt. cap
377.26B
Avg. vol.
39.72K
Volume
30.40K
Dividend
0.88%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
36.53
52-wk high
₹2,391.25
52-wk low
₹1,575.00
EPS
₹62.28
No. of employees
4K
News stories
From sources across the web
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4.35K
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteglandpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.06B
14.87B
16.95B
17.43B
Cost of goods sold
5.67B
6.04B
6.31B
6.44B
Cost of revenue
5.67B
6.04B
6.31B
6.44B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08B
3.85B
4.24B
4.12B
Operating expense
6.72B
6.75B
7.37B
6.94B
Total operating expenses
12.39B
12.79B
13.68B
13.38B
Operating income
2.67B
2.08B
3.27B
4.04B
Other non operating income
575.27M
841.62M
631.73M
1.11B
EBT including unusual items
3.13B
2.84B
3.62B
5.06B
EBT excluding unusual items
3.13B
2.84B
3.86B
5.06B
Income tax expense
972.59M
1.00B
1.01B
1.39B
Effective tax rate
31.10%
35.30%
27.79%
27.51%
Other operating expenses
1.63B
1.84B
2.06B
1.74B
Net income
2.15B
1.84B
2.61B
3.67B
Net profit margin
14.31%
12.35%
15.42%
21.04%
Earnings per share
13.33
11.15
16.98
22.23
Interest and investment income
-
-
-
-
Interest expense
-114.96M
-78.23M
-39.30M
-100.30M
Net interest expenses
-114.96M
-78.23M
-39.30M
-100.30M
Depreciation and amortization charges
1.01B
1.06B
1.08B
1.09B
EBITDA
3.57B
3.11B
4.17B
5.10B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer